These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32153362)

  • 1. Amide Proton Transfer Imaging in Predicting Isocitrate Dehydrogenase 1 Mutation Status of Grade II/III Gliomas Based on Support Vector Machine.
    Han Y; Wang W; Yang Y; Sun YZ; Xiao G; Tian Q; Zhang J; Cui GB; Yan LF
    Front Neurosci; 2020; 14():144. PubMed ID: 32153362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
    Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
    J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
    Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
    Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting.
    Sakai Y; Yang C; Kihira S; Tsankova N; Khan F; Hormigo A; Lai A; Cloughesy T; Nael K
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33121211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomics model based on DCE-MRI and DWI may improve the prediction of estimating IDH1 mutation and angiogenesis in gliomas.
    Wang J; Hu Y; Zhou X; Bao S; Chen Y; Ge M; Jia Z
    Eur J Radiol; 2022 Feb; 147():110141. PubMed ID: 34995947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach.
    Cao M; Suo S; Zhang X; Wang X; Xu J; Yang W; Zhou Y
    Biomed Res Int; 2021; 2021():1235314. PubMed ID: 33553421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma.
    Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y
    Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features.
    Peng H; Huo J; Li B; Cui Y; Zhang H; Zhang L; Ma L
    J Magn Reson Imaging; 2021 May; 53(5):1399-1407. PubMed ID: 33179832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using radiomics based on multicenter magnetic resonance images to predict isocitrate dehydrogenase mutation status of gliomas.
    Liu Y; Zheng Z; Wang Z; Qian X; Yao Z; Cheng C; Zhou Z; Gao F; Dai Y
    Quant Imaging Med Surg; 2023 Apr; 13(4):2143-2155. PubMed ID: 37064376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.
    Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H
    J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
    Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
    Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics.
    Zhuo Z; Qu L; Zhang P; Duan Y; Cheng D; Xu X; Sun T; Ding J; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4426-4436. PubMed ID: 34131804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
    Xu X; Zhang X; Tian Q; Wang H; Cui LB; Li S; Tang X; Li B; Dolz J; Ayed IB; Liang Z; Yuan J; Du P; Lu H; Liu Y
    J Magn Reson Imaging; 2019 May; 49(5):1489-1498. PubMed ID: 30252978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 3D magnetic resonance fingerprinting radiomics in adult brain tumors: a feasibility study.
    Tippareddy C; Onyewadume L; Sloan AE; Wang GM; Patil NT; Hu S; Barnholtz-Sloan JS; Boyacıoğlu R; Gulani V; Sunshine J; Griswold M; Ma D; Badve C
    Eur Radiol; 2023 Feb; 33(2):836-844. PubMed ID: 35999374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Texture Retrieving Model for Multimodal MR Image-Based Support Vector Machine for Classifying Glioma.
    Yang Y; Yan LF; Zhang X; Nan HY; Hu YC; Han Y; Zhang J; Liu ZC; Sun YZ; Tian Q; Yu Y; Sun Q; Wang SY; Zhang X; Wang W; Cui GB
    J Magn Reson Imaging; 2019 May; 49(5):1263-1274. PubMed ID: 30623514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
    Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
    Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.
    Zhang X; Xu X; Tian Q; Li B; Wu Y; Yang Z; Liang Z; Liu Y; Cui G; Lu H
    J Magn Reson Imaging; 2017 Nov; 46(5):1281-1288. PubMed ID: 28199039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
    Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
    Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma.
    Huang WY; Wen LH; Wu G; Hu MZ; Zhang CC; Chen F; Zhao JN
    J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):110-120. PubMed ID: 33475317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.